Prévisions du marché des bioprocédés en Asie-Pacifique jusqu\'en 2031 - Analyse régionale - par produit (instruments et consommables et accessoires), échelle d\'exploitation (opérations commerciales et opérations cliniques), processus (bioprocédés en aval et bioprocédés en amont), application (anticorps monoclonaux, vaccins, protéines recombinantes, thérapie cellulaire et génique, et autres) et utilisateur final (sociétés biopharmaceutiques, organisations de fabrication sous contrat, et autres)
La demande croissante de médecine personnalisée stimule le marché des bioprocédés en Asie-Pacifique
La transformation du secteur de la santé d\'une approche unique à une approche ciblée accroît la demande de médecine personnalisée. La médecine de précision est considérée comme l\'une des approches les plus prometteuses pour s\'attaquer aux problèmes de santé tels que le cancer, les maladies neurodégénératives et les maladies génétiques rares. Les innovations dans la production de médicaments personnalisés sont susceptibles d\'avoir un impact sur l\'ensemble du secteur, et les technologies à usage unique visant une production en plus petit volume ont des applications potentielles dans la bioproduction de protéines, en particulier dans les processus en aval. Les approches personnalisées et différenciées de la médecine conduisent à un besoin d\'une gamme plus large de produits, dont beaucoup sont destinés à un groupe relativement restreint de patients. Par conséquent, une approche fondamentalement différente de la production et de la distribution de produits biologiques peut être nécessaire. La médecine de précision utilise les informations génomiques d\'un individu pour offrir un traitement ciblé pour une indication particulière. Le nombre croissant de maladies orphelines a augmenté la demande de produits biologiques et de médicaments, ce qui a ensuite stimulé la croissance des médicaments personnalisés. En 2019, la FDA a approuvé environ 12 médicaments personnalisés pour s\'attaquer aux causes profondes de la maladie et a davantage intégré la médecine de précision aux soins cliniques. En outre, les efforts croissants du gouvernement renforcent les activités de recherche en médecine personnalisée. Par exemple, en février 2020, le National Human Genome Research Institute (NHGRI) a annoncé la création d\'un nouveau programme de médecine de précision et de génomique. Ce programme se concentre sur l\'innovation des outils génomiques et informatiques pour un meilleur diagnostic et traitement des maladies. Les médicaments personnalisés tirent parti des avancées de la génétique et de la bioinformatique pour cibler des populations de patients spécifiques et traiter des maladies auparavant incurables. La médecine personnalisée utilise des techniques de biotraitement pour développer des thérapies sur mesure. De l\'isolement de cellules spécifiques au développement de traitements spécifiques au patient, les étapes de biotraitement sont essentielles pour produire des traitements adaptés à chaque patient. Par conséquent, la demande croissante de médecine personnalisée devrait offrir des opportunités de croissance importantes aux acteurs opérant sur le marché des bioprocédés au cours de la période de prévision.
Aperçu du marché des bioprocédés en Asie-Pacifique
Le marché des bioprocédés en Asie-Pacifique est segmenté en Chine, au Japon, en Inde, en Corée du Sud, en Australie et dans le reste de l\'Asie-Pacifique. La croissance du marché dans ces pays est attribuée à la prévalence croissante des maladies chroniques et à des politiques de remboursement favorables. De plus, les stratégies d\'expansion et de lancement de produits mises en œuvre par les acteurs du marché devraient contribuer à la croissance du marché des technologies de bioprocédés dans la région. La Chine représentait la plus grande part du marché en 2023, et l\'Inde devrait enregistrer un TCAC important sur le marché au cours de la période de prévision. L\'industrie biopharmaceutique en Chine connaît un changement considérable, évoluant d\'un paysage axé sur les génériques vers un pôle d\'innovation florissant. De plus, les progrès de l\'industrialisation et l\'application de nouveaux médicaments, de dispositifs médicaux haut de gamme et de techniques contribuent à la croissance du marché des bioprocédés en Chine. Ainsi, un nombre croissant de centres de recherche, un financement gouvernemental croissant et des initiatives constantes prises par les acteurs du marché pour une expansion géographique alimentent la croissance du marché du biotraitement en Asie-Pacifique.
Chiffre d\'affaires et prévisions du marché du biotraitement en Asie-Pacifique jusqu\'en 2031 (en millions de dollars américains)
Segmentation du marché du biotraitement en Asie-Pacifique
Le marché du biotraitement en Asie-Pacifique est classé en produit, échelle d\'opération, processus, application, utilisateur final et pays.
Sur la base du produit, le marché du biotraitement en Asie-Pacifique est divisé en instruments et consommables et accessoires. Le segment des instruments détenait une part de marché plus importante en 2023. En outre, le segment des instruments est sous-segmenté en dispositifs de filtration, bioréacteurs, systèmes de chromatographie, centrifugeuses, dispositifs de séchage et autres. De plus, le sous-segment des bioréacteurs est classé en échelle pilote, échelle réelle et échelle de laboratoire. En outre, le sous-segment des systèmes de chromatographie est segmenté en chromatographie liquide, chromatographie gazeuse et autres. Français De plus, le segment des consommables et accessoires est sous-segmenté en réactifs, milieux de culture cellulaire, résines de chromatographie et autres.
En termes d\'échelle d\'exploitation, le marché du biotraitement en Asie-Pacifique est divisé en opérations commerciales et opérations cliniques. Le segment des opérations commerciales détenait une part de marché plus importante en 2023.
Par processus, le marché du biotraitement en Asie-Pacifique est divisé en biotraitements en aval et en biotraitements en amont. Le segment des biotraitements en aval détenait une part de marché plus importante en 2023.
Sur la base de l\'application, le marché du biotraitement en Asie-Pacifique est classé en anticorps monoclonaux, vaccins, protéines recombinantes, thérapie cellulaire et génique, et autres. Le segment des anticorps monoclonaux détenait la plus grande part de marché en 2023.
En termes d\'utilisateur final, le marché du biotraitement en Asie-Pacifique est classé en sociétés biopharmaceutiques, organisation de fabrication sous contrat et autres. Français Le segment des sociétés biopharmaceutiques détenait la plus grande part de marché en 2023.
Par pays, le marché des bioprocédés en Asie-Pacifique est segmenté en Chine, Inde, Japon, Corée du Sud, Australie et reste de l\'Asie-Pacifique. La Chine a dominé la part de marché des bioprocédés en Asie-Pacifique en 2023.
Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc et Cytiva US LLC. sont quelques-unes des principales entreprises opérant sur le marché des bioprocédés en Asie-Pacifique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioprocessing Market Landscape
4.1 Ecosystem Analysis
4.1.1 List of Vendors in the Value Chain
5. Asia Pacific Bioprocessing Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Biopharmaceutical Industry
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing
5.3 Market Opportunities
5.3.1 Proliferating Demand for Personalized Medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact of Drivers and Restraints:
6. Bioprocessing Market - Asia Pacific Analysis
6.1 Asia Pacific Bioprocessing Market Overview
6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031
7. Asia Pacific Bioprocessing Market Analysis - by Product
7.1 Overview
7.2 Instruments
7.2.1 Overview
7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
7.3 Consumables & Accessories
7.3.1 Overview
7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
8. Asia Pacific Bioprocessing Market Analysis - by Scale of Operation
8.1 Overview
8.2 Commercial Operations
8.2.1 Overview
8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Operations
8.3.1 Overview
8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Bioprocessing Market Analysis - by Process
9.1 Overview
9.2 Downstream Bioprocess
9.2.1 Overview
9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Upstream Bioprocess
9.3.1 Overview
9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Bioprocessing Market Analysis - by Application
10.1 Overview
10.2 Monoclonal Antibodies
10.2.1 Overview
10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Vaccines
10.3.1 Overview
10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Recombinant Protein
10.4.1 Overview
10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Cell & Gene Therapy
10.5.1 Overview
10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11. Asia Pacific Bioprocessing Market Analysis - by End User
11.1 Overview
11.2 Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Contract Manufacturing Organization
11.3.1 Overview
11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12. Asia Pacific Bioprocessing Market - Country Analysis
12.1 Asia Pacific
12.1.1 Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
12.1.1.1 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.2 China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 China: Bioprocessing Market Breakdown, by Product
12.1.1.2.1.1 China: Bioprocessing Market Breakdown, by Instruments
12.1.1.2.1.1.1 China: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.2.1.1.2 China: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.2.2 China: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.2.3 China: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.2.4 China: Bioprocessing Market Breakdown, by Process
12.1.1.2.5 China: Bioprocessing Market Breakdown, by Application
12.1.1.2.6 China: Bioprocessing Market Breakdown, by End User
12.1.1.3 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.4 India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.4.1 India: Bioprocessing Market Breakdown, by Product
12.1.1.4.1.1 India: Bioprocessing Market Breakdown, by Instruments
12.1.1.4.1.1.1 India: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.4.1.1.2 India: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.4.1.2 India: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.4.2 India: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.4.3 India: Bioprocessing Market Breakdown, by Process
12.1.1.4.4 India: Bioprocessing Market Breakdown, by Application
12.1.1.4.5 India: Bioprocessing Market Breakdown, by End User
12.1.1.5 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.5.1 Overview
12.1.1.6 Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.6.1 Japan: Bioprocessing Market Breakdown, by Product
12.1.1.6.1.1 Japan: Bioprocessing Market Breakdown, by Instruments
12.1.1.6.1.1.1 Japan: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.6.1.1.2 Japan: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.6.1.2 Japan: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.6.2 Japan: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.6.3 Japan: Bioprocessing Market Breakdown, by Process
12.1.1.6.4 Japan: Bioprocessing Market Breakdown, by Application
12.1.1.6.5 Japan: Bioprocessing Market Breakdown, by End User
12.1.1.7 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.7.1 Overview
12.1.1.8 South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.8.1 South Korea: Bioprocessing Market Breakdown, by Product
12.1.1.8.1.1 South Korea: Bioprocessing Market Breakdown, by Instruments
12.1.1.8.1.1.1 South Korea: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.8.1.1.2 South Korea: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.8.1.2 South Korea: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.8.2 South Korea: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.8.3 South Korea: Bioprocessing Market Breakdown, by Process
12.1.1.8.4 South Korea: Bioprocessing Market Breakdown, by Application
12.1.1.8.5 South Korea: Bioprocessing Market Breakdown, by End User
12.1.1.9 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.9.1 Overview
12.1.1.10 Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.10.1 Australia: Bioprocessing Market Breakdown, by Product
12.1.1.10.1.1 Australia: Bioprocessing Market Breakdown, by Instruments
12.1.1.10.1.1.1 Australia: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.10.1.1.2 Australia: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.10.1.2 Australia: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.10.2 Australia: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.10.3 Australia: Bioprocessing Market Breakdown, by Process
12.1.1.10.4 Australia: Bioprocessing Market Breakdown, by Application
12.1.1.10.5 Australia: Bioprocessing Market Breakdown, by End User
12.1.1.11 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.11.1 Overview
12.1.1.12 Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
12.1.1.12.1 Rest of APAC: Bioprocessing Market Breakdown, by Product
12.1.1.12.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Instruments
12.1.1.12.1.1.1 Rest of APAC: Bioprocessing Market Breakdown, by Bioreactors
12.1.1.12.1.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Chromatography Systems
12.1.1.12.1.2 Rest of APAC: Bioprocessing Market Breakdown, by Consumables & Accessories
12.1.1.12.2 Rest of APAC: Bioprocessing Market Breakdown, by Scale of Operation
12.1.1.12.3 Rest of APAC: Bioprocessing Market Breakdown, by Process
12.1.1.12.4 Rest of APAC: Bioprocessing Market Breakdown, by Application
12.1.1.12.5 Rest of APAC: Bioprocessing Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Bioprocessing Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Getinge AB
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Thermo Fisher Scientific Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sartorius AG
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Corning Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bio-Rad Laboratories Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 3M Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Eppendorf SE
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Repligen Corp
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Entegris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Agilent Technologies Inc
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Cytiva US LLC
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioprocessing Market Segmentation
Table 2. List of Vendors
Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments
Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors
Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems
Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories
Table 7. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 8. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 9. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 10. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 11. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 12. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 13. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 14. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 16. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 17. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 18. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 19. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 20. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 21. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 22. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 23. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 24. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 25. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 26. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 27. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 29. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 30. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 31. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 32. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 33. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 34. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 35. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 36. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 37. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 38. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 39. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 40. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 41. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 42. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 43. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 44. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 45. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 46. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 47. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 48. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 49. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 50. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 51. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 52. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product
Table 53. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments
Table 54. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors
Table 55. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems
Table 56. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories
Table 57. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation
Table 58. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process
Table 59. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 60. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User
Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market
Table 62. Recent Organic Growth Strategies in the Bioprocessing Market
Table 63. Glossary of Terms, Bioprocessing Market
?
List of Figures
Figure 1. Asia Pacific Bioprocessing Market Segmentation, by Country
Figure 2. Bioprocessing Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031
Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)
Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)
Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)
Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)
Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)
Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. Asia Pacific: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)
Figure 25. Asia Pacific: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 26. China: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. India: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Japan: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 29. South Korea: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 30. Australia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 31. Rest of APAC: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)
Figure 32. Growth Strategies in the Bioprocessing Market
- Getinge AB
- Thermo Fisher Scientific Inc
- Sartorius AG
- Corning Inc
- Bio-Rad Laboratories Inc
- Merck KGaA
- 3M Co
- Eppendorf SE
- Repligen Corp
- Entegris Inc
- Agilent Technologies Inc
- Cytiva US LLC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioprocessing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioprocessing market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.